Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.
Brittany L BunchYingyu MaKristopher AttwoodLauren AmableWei LuoCarl MorrisonKhurshid A GuruAnna WoloszynskaPamela A HershbergerDonald L TrumpCandace S JohnsonPublished in: Cancer medicine (2019)
Our data suggest that VitD deficiency could be a biomarker for poor response to cisplatin, and pretreating with VitD can increase the apoptotic response to cisplatin through VDR and TAp73 signaling crosstalk.